Evidence map›Paper›PMID 38892317›Full record

ArticleInternational journal of molecular sciences2024

The Role of TLR7 and TLR9 in the Pathogenesis of Systemic Sclerosis.

Chenyang Wang, Kyosuke Oishi, Tadahiro Kobayashi, Ko Fujii, Motoki Horii, Natsumi Fushida, Tasuku Kitano, Shintaro Maeda, Yuichi Ikawa, Akito Komuro and 2 more

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Chenyang WangDepartment of Dermatology, Kanazawa University Graduate School of Medical Sciences, Kanazawa 920-8641, Japan.
Kyosuke OishiDepartment of Dermatology, Kanazawa University Graduate School of Medical Sciences, Kanazawa 920-8641, Japan.ORCID 0000-0002-9511-0100
Tadahiro KobayashiDepartment of Dermatology, Kanazawa University Graduate School of Medical Sciences, Kanazawa 920-8641, Japan.ORCID 0000-0003-4367-2336
Ko FujiiDepartment of Dermatology, Kanazawa University Graduate School of Medical Sciences, Kanazawa 920-8641, Japan.
Motoki HoriiDepartment of Dermatology, Kanazawa University Graduate School of Medical Sciences, Kanazawa 920-8641, Japan.
Natsumi FushidaDepartment of Dermatology, Kanazawa University Graduate School of Medical Sciences, Kanazawa 920-8641, Japan.
Tasuku KitanoDepartment of Dermatology, Kanazawa University Graduate School of Medical Sciences, Kanazawa 920-8641, Japan.
Shintaro MaedaDepartment of Dermatology, Kanazawa University Graduate School of Medical Sciences, Kanazawa 920-8641, Japan.
Yuichi IkawaDepartment of Dermatology, Kanazawa University Graduate School of Medical Sciences, Kanazawa 920-8641, Japan.
Akito KomuroDepartment of Dermatology, Kanazawa University Graduate School of Medical Sciences, Kanazawa 920-8641, Japan.
Yasuhito HamaguchiDepartment of Dermatology, Kanazawa University Graduate School of Medical Sciences, Kanazawa 920-8641, Japan.
Takashi MatsushitaDepartment of Dermatology, Kanazawa University Graduate School of Medical Sciences, Kanazawa 920-8641, Japan.

Funding

Japan Society for the Promotion of Science 21K08320
6 · The paper itself

Abstract

The bleomycin-induced scleroderma model is a well-established and dependable method for creating a mouse model of SSc (systemic sclerosis). In the field of skin connective tissue diseases, increasing evidence from clinical and animal experiments suggests that TLRs (Toll-like receptors) play an important role in several diseases. This study aimed to determine the role of TLR7 (Toll-like receptor 7) and TLR9 (Toll-like receptor 9) in the mechanisms of immune abnormalities and fibrosis in SSc. This study used TLR7-KO mice (TLR7-knockout mice with a balb/c background) and TLR9-KO mice (TLR9-knockout mice with a balb/c background) as well as WT mice (wild-type balb/c mice). All three kinds of mice were induced by BLM (bleomycin) in a scleroderma model as the experimental group; meanwhile, WT mice treated with PBS (phosphate-buffered saline) were used as the control group. We analyzed the fibrotic phenotype and the immunological abnormality phenotype of TLR7-deficient and TLR9-deficient mice in the SSc disease model using flow cytometry, RT-PCR (reverse transcription-polymerase chain reaction), a histological examination, and IHC (immunohistochemical staining). In a mouse model of SSc disease, the deletion of TLR7 attenuated skin and lung fibrosis, while the deletion of TLR9 exacerbated skin and lung fibrosis. The deletion of TLR7 resulted in a relative decrease in the infiltration and expression of various pro-inflammatory and fibrotic cells and cytokines in the skin. On the other hand, the deletion of TLR9 resulted in a relative increase in the infiltration and expression of various pro-inflammatory and cytokine-inhibiting cells and cytokines in the skin. Under the influence of pDCs (plasmacytoid dendritic cells), the balances of Beff/Breg (IL-6 + CD19 + B cell/IL-10 + CD19 + B cell), Th17/Treg (IL-17A + CD4 + T cell/Foxp3 + CD25 + CD4 + T cell), M1/M2 (CD86 + macrophage/CD206 + macrophage), and Th1/Th2 (TNFα + CD3 + CD4 + T cell/IL-4 + CD3 + CD4 + T cell) were biased towards the suppression of inflammation and fibrosis as a result of the TLR7 deletion. Comparatively, the balance was biased towards promoting inflammation and fibrosis due to the TLR9 deletion. In the SSc model, TLR7 promoted inflammation and fibrosis progression, while TLR9 played a protective role. These results suggest that TLR7 and TLR9 play opposite roles in triggering SSc to produce immune system abnormalities and skin fibrosis.

Indexed as

Disease Models, AnimalMice, KnockoutScleroderma, SystemicToll-Like Receptor 7Toll-Like Receptor 9AnimalsBleomycinCytokinesFibrosisMembrane GlycoproteinsMiceMice, Inbred BALB CPulmonary FibrosisSkinBleomycinCytokinesMembrane GlycoproteinsTlr7 protein, mouseTlr9 protein, mouseToll-Like Receptor 7Toll-Like Receptor 9B cellsEffector B cellspDCsplasmacytoid dendritic cellsRegulatory B cellssystemic sclerosisTh17TLR7TLR9Toll-like receptorsTreg

Identifiers

PMID38892317
PMCPMC11172923

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.